Clinical Trial Update: Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for neoadjuvant nivolumab or placebo plus chemotherapy followed by surgery and adjuvant treatment in resectable esophageal squamous cell c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN